KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to $71.4 million.

  • NovoCure's Cash from Investing Activities rose 60083.39% to $71.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.7 million, marking a year-over-year increase of 50314.88%. This contributed to the annual value of -$140.2 million for FY2024, which is 17615.72% down from last year.
  • Latest data reveals that NovoCure reported Cash from Investing Activities of $71.4 million as of Q3 2025, which was up 60083.39% from $36.0 million recorded in Q2 2025.
  • In the past 5 years, NovoCure's Cash from Investing Activities registered a high of $302.7 million during Q3 2021, and its lowest value of -$499.1 million during Q4 2021.
  • Moreover, its 5-year median value for Cash from Investing Activities was $10.2 million (2024), whereas its average is -$7.4 million.
  • Per our database at Business Quant, NovoCure's Cash from Investing Activities skyrocketed by 604946.52% in 2022 and then tumbled by 259439.45% in 2024.
  • Over the past 5 years, NovoCure's Cash from Investing Activities (Quarter) stood at -$499.1 million in 2021, then soared by 74.34% to -$128.1 million in 2022, then soared by 176.92% to $98.5 million in 2023, then crashed by 122.55% to -$22.2 million in 2024, then soared by 421.62% to $71.4 million in 2025.
  • Its last three reported values are $71.4 million in Q3 2025, $36.0 million for Q2 2025, and -$6.5 million during Q1 2025.